Echo Street Capital Management LLC Abb Vie Inc. Transaction History

Echo Street Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $827,524 - $1.03 Million	6,245 Added 251.11%	8,732 $1.18 Million
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $359,645 - $414,184	2,487 New	2,487 $396,000
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $1.15 Million - $1.3 Million	-10,778 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $812,115 - $904,743	7,719 Added 252.34%	10,778 $1.21 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $312,935 - $344,504	3,059 New	3,059 $331,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.